Golino, P <br/><br/>
Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.  [electronic resource] 

 -  Journal of the American College of Cardiology  Feb 1993 
 - 493-501 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0735-1097 
<br/><br/><label>Standard No.: </label>10.1016/0735-1097(93)90694-v  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aspirin--pharmacology<br/>Bridged Bicyclo Compounds, Heterocyclic<br/>Fatty Acids, Unsaturated<br/>Female<br/>Hydrazines--pharmacology<br/>Imidazoles--pharmacology<br/>Male<br/>Myocardial Infarction--physiopathology<br/>Myocardial Reperfusion Injury--physiopathology<br/>Pentanoic Acids--pharmacology<br/>Platelet Aggregation--drug effects<br/>Prostaglandin Endoperoxides--physiology<br/>Prostaglandin Endoperoxides, Synthetic--pharmacology<br/>Pyridines--pharmacology<br/>Rabbits<br/>Receptors, Thromboxane--antagonists & inhibitors<br/>Thromboxane-A Synthase--antagonists & inhibitors